Sebastien Goutal
Paris, 91401, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Head-to-head comparison of [18F]CHL2205 versus [18F]T008 as PET radioligands to study brain cholesterol homeostasis in rodent models and nonhuman primates.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 06, 2026
Whole-Body Dynamic PET Imaging of Half-Life Extended Variable Domains of Heavy Chain-Only Antibodies: Beyond Blood Pharmacokinetics.
Journal: Molecular pharmaceutics
Published: January 15, 2026
Synthesis, Labeling, and Biological Evaluation of P2Y12 Receptor Radioligands for Positron Emission Tomography Imaging of Neuroinflammation.
Journal: ACS chemical neuroscience
Published: June 24, 2025
Quantitative monitoring of ketamine's impact on synaptic density using 11C-UCB-J PET imaging in the corticosterone mouse model of anxiety/depression.
Journal: Molecular psychiatry
Published: February 13, 2025
Brain glucose metabolism as a neuronal substrate of the abnormal behavioral response to stress in the mdx mouse, a model of Duchenne muscular dystrophy.
Journal: Neurobiology of disease
Published: November 20, 2024
Decreased opioid receptor availability and impaired neurometabolic coupling as signatures of morphine tolerance in male rats: A positron emission tomography study.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 06, 2024
Synaptic Vesicle 2A (SV2A) Positron Emission Tomography (PET) Imaging as a Marker of Therapeutic Response in a Mouse Model of Depression.
Journal: ACS pharmacology & translational science
Published: October 25, 2024
Imaging the impact of sex and age on OATP function in humans: Consequences for whole-body pharmacokinetics and liver exposure.
Journal: Acta pharmaceutica Sinica. B
Published: September 18, 2024
Brain delivery enabled by transient blood-brain barrier disruption induced by regadenoson: a PET imaging study.
Journal: Expert opinion on drug delivery
Published: June 17, 2024
Brain Glucose Metabolism as a Readout of the Central Nervous System Impact of Cigarette Smoke Exposure and Withdrawal and the Effects of NFL-101, as an Immune-Based Drug Candidate for Smoking Cessation Therapy.
Journal: ACS chemical neuroscience
Published: June 14, 2024
Last Updated: 09/26/2026